Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring

Biotricity provides remote cardiac monitoring to patients through its biokit and Bioflux services. Biotricity's medtech technologies can be found in Samsung Watch4 devices and as a standalone platform at your local physical or health services provider.

Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) is reforming the healthcare market as one of the fastest-growing companies in medtech. The company bridges the gap in remote cardiac monitoring, preventive and chronic care management by using the power of IoT (internet of things), wearables, and connected devices.  Not only does the company offer real-time, […]

Continue Reading

Biotricity Reports Q1 Earnings at 290% for FY2022

Medtech Cardiac Monitoring Device, Wearable, Biotricity, Bioflux, Samsung, Watch4,

Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always connected, these wearable devices have been giving power back to those suffering from chronic cardiac conditions and simultaneous comorbidities — the simultaneous presence of two […]

Continue Reading